You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA antibodies

Showing 1 - 25 of 5,169
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obstetrical History and Anti-HLA Antibodies Level

Not yet recruiting
  • Blood Donors
  • Anti-HLA Antibody
  • Obstetrical history
  • Anti-HLA Antibody tests
  • Bordeaux, France
    Etablissement Français du Sang Nouvelle Aquitaine
Aug 25, 2023

Rejection Diagnosis in Kidney Transplants Patients

Completed
  • Kidney Transplantation
  • +2 more
  • Kidney transplantation
  • Paris, France
    Hopital Saint-Louis
Feb 9, 2022

Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

Active, not recruiting
  • Kidney Failure, Chronic
  • +6 more
  • Los Angeles, California
    Norko Ammerman
Mar 25, 2022

Kidney Transplant Rejection Trial in Warsaw (Anti-HLA donor-specific antibodies monitoring)

Active, not recruiting
  • Kidney Transplant Rejection
  • Anti-HLA donor-specific antibodies monitoring
  • Warsaw, Poland
    Department of Transplantation Medicine, Nephrology and Internal
Mar 8, 2021

Immunoglobulins, Plasmapheresis and Rituximab in Lung

Recruiting
  • Lung Transplantation
  • Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
  • blood samples
  • Hannover, Germany
    Hannover Medical School, Department of Cardiothoracic, Transplan
Aug 30, 2021

Platelet Transfusion Refractoriness

Recruiting
  • Platelet Transfusion Refractoriness
  • platelet transfusion
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
May 30, 2022

Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

Active, not recruiting
  • Antibody-mediated Rejection
  • +5 more
  • Los Angeles, California
    Norko Ammerman
Mar 25, 2022

Donor-specific Antibodies After Liver Transplantation

Completed
  • Liver Transplant
    • Lille, France
      CHRU, Hôpital Claude Huriez
    Mar 24, 2021

    Kidney Transplant Rejection Trial in Los Angeles (Extended-release tacrolimus, Immediate-release tacrolimus)

    Recruiting
    • Kidney Transplant Rejection
    • Extended-release tacrolimus
    • Immediate-release tacrolimus
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jan 18, 2022

    DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors

    Completed
    • Hematologic Diseases
    • Stem Cell Transplant Complications
      • Ancona, Italy
      • +24 more
      Aug 19, 2021

      Transplants and Implants Trial in Cincinnati (Carfilzomib, Rituximab)

      Unknown status
      • Transplants and Implants
      • Cincinnati, Ohio
      • +1 more
      Jun 29, 2020

      Other Complication of Kidney Transplant, Renal Transplant Rejection Trial in Spain (Prednisone withdrawal, Prednisone

      Completed
      Has Results
      • Other Complication of Kidney Transplant
      • Renal Transplant Rejection
      • Prednisone withdrawal
      • Prednisone continuation
      • Barcelona, Spain
      • +4 more
      Apr 2, 2020

      Development of Antibodies Against Transplant Kidney After

      Completed
      • Acute Infection
      • Kidney Failure
      • Level of antibodies
      • Ostrava, Moravian-Silesian Region, Czechia
        University Hospital Ostrava
      Sep 8, 2023

      Quantitative Parameters of HLA-DQ Antibodies in Lung

      Completed
      • Lung Transplantation
      • +2 more
        • Bordeaux, France
        • +4 more
        Apr 28, 2020

        First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney

        Active, not recruiting
        • Kidney Diseases
        • +5 more
        • Booster dose of mRNA vaccine
        • Praha, Czechia
          Institute for Clinical and Experimental Medicine
        Aug 2, 2022

        Subclass of Donor-specific Antibody asRisk Factor of Antibody

        Active, not recruiting
        • Antibody-mediated Rejection
          • Montpellier, Hérault, France
            CHU Lapeyronie
          Jan 18, 2023

          Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

          Enrolling by invitation
          • Antibody-mediated Rejection
          • Cardiac Transplant
          • Daratumumab and hyaluronidase-fihj
          • Rochester, Minnesota
            Mayo Clinic Rochester
          Apr 11, 2022

          Expanding Scope of Post-transplant HLA-specific Antibody

          Not yet recruiting
          • Kidney Transplant
          • +7 more
          • cf-DNA
          • +2 more
          • Liverpool, Merseyside, United Kingdom
            Liverpool University Hospitals NHS Foundation Trust
          Aug 29, 2023

          HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

          Recruiting
          • Drug Monitoring
          • Inflammatory Bowel Diseases
          • Tumor necrosis factor (TNF)-alpha inhibitors
          • Valladolid, Spain
            Hospital Universitario Rio Hortega
          Aug 8, 2023

          Lung Graft Dysfunction Trial (Blood collection T0, Blood collection 6 months)

          Not yet recruiting
          • Lung Graft Dysfunction
          • Blood collection T0
          • Blood collection 6 months
          • (no location specified)
          Oct 27, 2023

          Cell-Free Nucleic Acids Trial (Cell free DNA analysis)

          Not yet recruiting
          • Cell-Free Nucleic Acids
          • Cell free DNA analysis
          • (no location specified)
          Jan 27, 2022

          Kidney Transplantation, Graft Failure Trial in Toulouse (Tocilizumab)

          Recruiting
          • Kidney Transplantation
          • Graft Failure
          • Toulouse, France
            CHU Toulouse
          Mar 15, 2022

          Trifecta-Heart cfDNA-MMDx Study

          Recruiting
          • Heart Transplant Rejection
          • MMDx diagnostic test
          • +2 more
          • Los Angeles, California
          • +9 more
          Aug 2, 2022

          Antibodies to White Blood Cells on Platelet Transfusion Patients

          Completed
          • Healthy
          • Transfusion Reactions
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Dec 11, 2019

            Nanoparticle for DSA Removal

            Recruiting
            • Kidney Failure
            • Presence of Donor Specific Antibodies
              • Zurich, ZH, Switzerland
                University Hospital Zurich, Division of Anaesthesiology
              Mar 11, 2022